Live
Home·Deals·Biopharmaceuticals·Zydus Lifesciences Limited acquires Agenus
SEO URLwww.firestrike.ai/deals/agenus-zydus-lifesciences-limited-acquisition-2026
acquisitionAnnounced · Jan 15, 2026BiopharmaceuticalsSource · CredibleArticle · Factual
Agenus
Zydus Lifesciences Limited
Agenus · Zydus Lifesciences Limited

Zydus Lifesciences Limited acquires Agenus

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
ShareXLinkedInEmail
Deal value
Target
Agenus
Agenus
NASDAQ: AGEN · Lexington, Massachusetts
Acquirer
Zydus Lifesciences Limited
Zydus Lifesciences Limited
Asset/Business Division Sale
Status
Completed

Zydus Lifesciences Limited agreed to acquire Agenus. Reported deal value: Undisclosed. Status: Completed. Sector: Biopharmaceuticals. Target headquarters context: Lexington, Massachusetts, United States.

This page summarizes publicly available information about the transaction as of 2026-01-15. Figures and status may change as filings and press coverage update.

Today at 9:58 AM Zydus Completes Agenus Biologics Facilities Acquisition And Launches U.S. CDMO Unit Zydus Lifesciences Limited announced it has completed a set of agreements with Agenus Inc. that transfers ownership of Agenus ’ biologics manufacturing facilities and operations to Zydus , establishing a new U.S. -based platform that will operate under a newly formed subsidiary, Zylidac Bio LLC

Deal timeline

Announced
Jan 15, 2026 · pulse2.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Biopharmaceuticals. Figures and status may change as sources update.

Sources: pulse2.com · Primary article · FireStrike proprietary index